Crescita Therapeutics Inc. (TSE:CTX – Get Free Report)’s stock price was up 9.4% during mid-day trading on Monday . The company traded as high as C$0.60 and last traded at C$0.58. Approximately 256,556 shares traded hands during mid-day trading, an increase of 1,601% from the average daily volume of 15,085 shares. The stock had previously closed at C$0.53.
Crescita Therapeutics Trading Up 9.4 %
The company has a 50-day moving average price of C$0.55 and a 200 day moving average price of C$0.57. The company has a current ratio of 2.70, a quick ratio of 2.29 and a debt-to-equity ratio of 5.77. The stock has a market capitalization of C$10.68 million, a P/E ratio of -3.94 and a beta of 1.69.
Crescita Therapeutics Company Profile
Crescita Therapeutics Inc, a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers (MMPE) and DuraPeel for the development of topicals containing cannabis and hemp.
Featured Articles
- Five stocks we like better than Crescita Therapeutics
- Basic Materials Stocks Investing
- Why NVIDIA Stock Could Soar Despite Wall Street Downgrades
- What Investors Need to Know About Upcoming IPOs
- Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or Hold
- There Are Different Types of Stock To Invest In
- 3 Hot New IPOs Defying the 2025 Market Slump
Receive News & Ratings for Crescita Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescita Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
